BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND STK11, LKB1, 6794, ENSG00000118046, Q15831, PJS AND Treatment
94 results:

  • 1. Oridonin inhibited epithelial-mesenchymal transition of laryngeal carcinoma by positively regulating lkb1/AMPK signaling.
    Kou B; Shi Y; Zhou Z; Yun Y; Wu Q; Zhou J; Liu W
    Int J Med Sci; 2024; 21(4):623-632. PubMed ID: 38464825
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Carnosic Acid against Lung cancer: Induction of Autophagy and Activation of Sestrin-2/lkb1/AMPK Signalling.
    O'Neill EJ; Sze NSK; MacPherson REK; Tsiani E
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396629
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
    Wang WN; Liu XT; Liang YM
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
    [No Abstract]    [Full Text] [Related]  

  • 4. BAY-3827 and SBI-0206965: Potent AMPK Inhibitors That Paradoxically Increase Thr172 Phosphorylation.
    Hawley SA; Russell FM; Ross FA; Hardie DG
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203624
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting lkb1 (liver kinase B1) activity.
    Yuan T; Zeng C; Liu J; Zhao C; Ge F; Li Y; Qian M; Du J; Wang W; Li Y; Liu Y; Dai X; Zhou J; Chen X; Ma S; Zhu H; He Q; Yang B
    Signal Transduct Target Ther; 2024 Jan; 9(1):11. PubMed ID: 38177135
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A Mammalian Conserved Circular RNA CircLARP1B Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism.
    Li J; Wang X; Shi L; Liu B; Sheng Z; Chang S; Cai X; Shan G
    Adv Sci (Weinh); 2024 Jan; 11(2):e2305902. PubMed ID: 37953462
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. STAT3/lkb1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.
    Pencik J; Philippe C; Schlederer M; Atas E; Pecoraro M; Grund-Gröschke S; Li WJ; Tracz A; Heidegger I; Lagger S; Trachtová K; Oberhuber M; Heitzer E; Aksoy O; Neubauer HA; Wingelhofer B; Orlova A; Witzeneder N; Dillinger T; Redl E; Greiner G; D'Andrea D; Östman JR; Tangermann S; Hermanova I; Schäfer G; Sternberg F; Pohl EE; Sternberg C; Varady A; Horvath J; Stoiber D; Malcolm TI; Turner SD; Parkes EE; Hantusch B; Egger G; Rose-John S; Poli V; Jain S; Armstrong CWD; Hoermann G; Goffin V; Aberger F; Moriggl R; Carracedo A; McKinney C; Kennedy RD; Klocker H; Speicher MR; Tang DG; Moazzami AA; Heery DM; Hacker M; Kenner L
    Mol Cancer; 2023 Aug; 22(1):133. PubMed ID: 37573301
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The efficacy of metformin as adjuvant to chemotherapy on IGF levels in non-diabetic female patients with progressive and non-progressive metastatic breast cancer.
    Essa NM; Elgendy MO; Gabr A; Mahmoud MM; Alharbi AA; Tashkandi HM; Salem HF; Harakeh S; Boshra MS
    Eur Rev Med Pharmacol Sci; 2023 Jun; 27(11):5200-5210. PubMed ID: 37318494
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
    Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
    Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.
    Hong L; Aminu M; Li S; Lu X; Petranovic M; Saad MB; Chen P; Qin K; Varghese S; Rinsurongkawong W; Rinsurongkawong V; Spelman A; Elamin YY; Negrao MV; Skoulidis F; Gay CM; Cascone T; Gandhi SJ; Lin SH; Lee PP; Carter BW; Wu CC; Antonoff MB; Sepesi B; Lewis J; Gibbons DL; Vaporciyan AA; Le X; Jack Lee J; Roy-Chowdhuri S; Routbort MJ; Gainor JF; Heymach JV; Lou Y; Wu J; Zhang J; Vokes NI
    Nat Commun; 2023 Feb; 14(1):695. PubMed ID: 36755027
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A subset of VEGFR-TKIs activates AMPK in lkb1-mutant lung cancer.
    Yang L; Zhang Q; Xiong Y; Dang Z; Xiao H; Chen Q; Dai X; Zhang L; Zhu J; Wang D; Li M
    Cancer Sci; 2023 Apr; 114(4):1651-1662. PubMed ID: 36459496
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Midkine noncanonically suppresses AMPK activation through disrupting the lkb1-STRAD-Mo25 complex.
    Xia T; Chen D; Liu X; Qi H; Wang W; Chen H; Ling T; Otkur W; Zhang CS; Kim J; Lin SC; Piao HL
    Cell Death Dis; 2022 Apr; 13(4):414. PubMed ID: 35487917
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases.
    Hasanvand A
    Inflammopharmacology; 2022 Jun; 30(3):775-788. PubMed ID: 35419709
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Elaiophylin reduces body weight and lowers glucose levels in obese mice by activating AMPK.
    Bao R; Meng Y; Zhang H; Yang C; Li W; Zhang C; Zhang J; Sun R; Li Z; Jiang W; Zhang C; Zhang C; Yuan HX; Dang Y
    Cell Death Dis; 2021 Oct; 12(11):972. PubMed ID: 34671010
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genomic characterization of hepatoid tumors: context matters.
    Lawlor RT; Mafficini A; Sciammarella C; Cantù C; Rusev BC; Piredda ML; Antonello D; Grimaldi S; Bonizzato G; Sperandio N; Marchegiani G; Malleo G; Pea A; Salvia R; Mombello A; Mazzoleni G; Nottegar A; Hanspeter E; Riva G; Tomezzoli A; Bencivenga M; de Manzoni G; Pedron S; Paolino G; Mattiolo P; Brosens LA; Silvestris N; Fassan M; Cooke SL; Beer PA; Milella M; Adsay VN; Cheng L; Scarpa A; Luchini C
    Hum Pathol; 2021 Dec; 118():30-41. PubMed ID: 34562502
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The opportunity of patient-journey studies for academic clinical research in oncology.
    Perrone F; Di Liello R; Gargiulo P; Arenare L; Guizzaro L; Chiodini P; Gallo C; Piccirillo MC
    BMJ Open; 2021 Sep; 11(9):e052871. PubMed ID: 34551954
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. stk11/lkb1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive?
    Di Federico A; De Giglio A; Parisi C; Gelsomino F
    Eur J Cancer; 2021 Nov; 157():108-113. PubMed ID: 34500370
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The protein kinase lkb1 promotes self-renewal and blocks invasiveness in glioblastoma.
    Caja L; Dadras MS; Mezheyeuski A; Rodrigues-Junior DM; Liu S; Webb AT; Gomez-Puerto MC; Ten Dijke P; Heldin CH; Moustakas A
    J Cell Physiol; 2022 Jan; 237(1):743-762. PubMed ID: 34350982
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Biology of primary breast cancer in older women beyond routine biomarkers.
    Parks RM; Alfarsi LH; Green AR; Cheung KL
    Breast Cancer; 2021 Sep; 28(5):991-1001. PubMed ID: 34165702
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Multidimensional mechanisms of metformin in cancer treatment.
    Singh-Makkar S; Pandav K; Hathaway D; Paul T; Youssef P
    Tumori; 2022 Apr; 108(2):111-118. PubMed ID: 34139918
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.